THE INTESTINAL FLORA AS A COMPLEMENT TO IMMUNOTHERAPY IN ONCOLOGY
06.11.2015 - Press release
The vital role of the intestinal flora in successful immunotherapy has just been revealed in a study published in the journal Science. Intestinal bacteria have been identified that can improve the therapeutic response to this drug and reduce a side-effect, “inflammatory colitis,” ...
Ovarian cancer: A promising approach for treating the most aggressive forms using targeted therapy
12.10.2015 - Press release
Thanks to work done at Institute Curie by a team led by Fatima Mechta-Grigoriou, Inserm Research Director, it is now possible to identify, among women with aggressive ovarian cancer, those who could benefit from a promising targeted therapy. ...
A new type of sarcoma identified
07.09.2015 - Press release
Inserm teams led by Prof. Jean-Yves Blay and Christophe Caux in Lyon , and by Franck Tirode and Olivier Delattre in Paris have just demonstrated a new genetic variant in tumours that had not been identified until now ...
A new virus in liver cancer
25.08.2015 - Press release
More than a cause of a simple infection, viruses are often involved in the development of serious diseases. Such is the case with liver cancer, which often develops in an organ that has been weakened by hepatitis B or C virus. Researchers ...
Production of iPS cells: discovery of the 5th element
08.07.2015 - Press release
Two teams of researchers from Inserm, CNRS, Centre Léon Bérard and Claude Bernard Lyon 1 University have discovered a molecule that may favour the production of these induced stem cells. ...
Restoring natural immunity against cancers
16.06.2015 - Press release
Scientists at the Institut Pasteur and Inserm have successfully increased the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. ...